2367
Thirty-six patients with AL received, in a three-month period, 51 cycles of combined chemotherapy which included, in all of them, cytosine arabinoside (ARA-C); among them, along with myelosuppression, five experienced fever, infectious complications, gastrointestinal tract symptoms and severe myalgias.
 five: Subject; five: Subject.Population; fever, infectious complications, gastrointestinal tract symptoms and severe myalgias: Effect; chemotherapy: Treatment; cytosine arabinoside (ARA-C): Treatment; cytosine arabinoside: Treatment.Drug; three-month: Treatment.Duration
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 five: Subject; five: Subject.Population; fever, infectious complications, gastrointestinal tract symptoms and severe myalgias: Effect; chemotherapy: Treatment; cytosine arabinoside (ARA-C): Treatment; cytosine arabinoside: Treatment.Drug; three-month: Treatment.Duration